Seres Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MCRB | SBTX.L | NIKI | IMUX | SER | OPTI.L | |
|---|---|---|---|---|---|---|
| Market cap | 20.99M | 13.45M | 5.27M | 108.34M | 42.93M | 5.78M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.4 | 27.5 | — | -3.4 | -1.6 | — |
| Price/book | 0.5 | 1.7 | 0.1 | 0.8 | 2.3 | 1.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −84.57% | −69.12% | −87.62% | +5.12% | −57.74% | −27.74% |
| Today | +6.63% | −1.14% | −3.98% | +4.47% | −7.65% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MCRB news ›Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
Oct 15, 2026 7:00am EDT Novel oral liquid formulation of SER-428 is designed for patients who cannot take oral capsules, including critically ill patients receiving nutrition via feeding tube Poster DetailsNumber: P-22Title: SER-428, an…
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why
Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report)’s share price crossed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $4.48 and traded as low as $2.70. Seres Therapeutics…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.